Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Other Medical Devices
mimedx.com

See what CB Insights has to offer

Founded Year

2008

Stage

PIPE | IPO

Market Cap

1.20B

About Mimedx

MiMedx is a medical device company focused exclusively on the spine. The company develops SaluDisc, a patented total disc replacement technology for sufferers of chronic back pain.

Mimedx Headquarter Location

1775 West Oak Commons Ct. NE

Marietta, Georgia, 30062,

United States

770-651-9100

Latest Mimedx News

NAACP To Present Historic Spingarn Medal To Regenerative Engineering Pioneer Cato T. Laurencin, M.D., Ph.D., At 112th Annual Convention

Jul 14, 2021

NAACP To Present Historic Spingarn Medal To Regenerative Engineering Pioneer Cato T. Laurencin, M.D., Ph.D., At 112th Annual Convention MIMEDX Applauds Dr. Laurencin on Receiving NAACP's Highest Honor for His Contributions to Emerging Medical Sciences that Advance Human Healing MARIETTA, Ga. Author: Jul 14, 2021 9:00 AM EDT MIMEDX Applauds Dr. Laurencin on Receiving NAACP's Highest Honor for His Contributions to Emerging Medical Sciences that Advance Human Healing MARIETTA, Ga., July 14, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company"), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today congratulates Cato T. Laurencin, M.D., Ph.D., Van Dusen Distinguished Endowed Professor at the University of Connecticut, on being awarded the Spingarn Medal, the NAACP's most prestigious honor. In addition to the academic pursuits for which he is being recognized, Dr. Laurencin serves as a member of the MIMEDX Board of Directors. Honoring his accomplishments in the fields of tissue regeneration, biomaterials science, nanotechnology, and regenerative engineering - a field he founded - Dr. Laurencin will receive the Spingarn Medal at the NAACP's 112 th Annual Convention today . Established in 1914 by the late Joel E. Spingarn, the medal is awarded annually for the highest or noblest achievement by a living African American during the preceding year or years in any honorable field. Timothy R. Wright, MIMEDX Chief Executive Officer, commented, "As a pioneer in the field of regenerative engineering, Dr. Laurencin's discoveries and achievements have pushed the boundaries of science in the service of human health and inspired countless other researchers to do the same. His addition to the Board of Directors at MIMEDX last fall has been invaluable and speaks to our shared mission - advancing science to improve patients' lives. We are fortunate to have the opportunity to learn from and build on his truly unique insights." An International Fellow in Biomaterials Science and Engineering, Dr. Laurencin received the Founders Award from the Society for Biomaterials for his work in advancing the science of the field. He is the first surgeon in history to be elected to all four national academies: the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. With more than 500 publications and patents, Dr. Laurencin also received the National Medal of Technology and Innovation, the nation's highest honor for technological achievement. "I feel incredibly honored and humbled to receive this historic award," said Dr. Laurencin. "My work has been carried out with the distinct purpose of making a meaningful difference in people's lives. This recognition demonstrates the importance of the advancements we've made in the field of regenerative engineering and underscores the need to keep innovation at the forefront of the industry." ABOUT NAACPFounded in 1909 in response to the ongoing violence against Black people around the country, the NAACP (National Association for the Advancement of Colored People) is the largest and most pre-eminent civil rights organization in the nation. Its mission is to secure the political, educational, social, and economic equality of rights to eliminate race-based discrimination and ensure the health and well-being of all persons. NOTE: The Legal Defense Fund — also referred to as the NAACP-LDF was founded in 1940 as a part of the NAACP, but separated in 1957 to become a completely separate entity. It is recognized as the nation's first civil and human rights law organization and shares the NAACP's commitment to equal rights. About MIMEDXMIMEDX is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a base business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. MIMEDX has supplied over two million allografts, through both direct and consignment shipments. For additional information, please visit  www.mimedx.com . Contact: InvestorsJack Howarth404-360-5681 investorrelations@mimedx.com

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Mimedx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Mimedx is included in 1 Expert Collection, including Neuroscience.

N

Neuroscience

2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

Mimedx Patents

Mimedx has filed 95 patents.

The 3 most popular patent topics include:

  • Stem cells
  • Developmental biology
  • Embryology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/10/2018

5/11/2021

Cardiac arrhythmia, Transcription factors, Growth factors, Cytokines, Cardiology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

9/10/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

5/11/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Cardiac arrhythmia, Transcription factors, Growth factors, Cytokines, Cardiology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Mimedx Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Mimedx Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.